What is Yield10 Bioscience?
Yield10 Bioscience, Inc. is an agricultural bioscience company dedicated to advancing crop technology to bolster crop yields and contribute to sustainable global food security. At the core of its innovation is the proprietary "GRAIN" (Gene Ranking Artificial Intelligence Network) gene discovery platform. This AI-driven system is instrumental in identifying gene targets that can enhance yield performance and value across major commercial food and feed crops. The company leverages its specialized Camelina oilseed platform to expedite the evaluation and field testing of new trait leads, facilitating the efficient translation of these traits into commercially significant crops. Headquartered in Woburn, Massachusetts, Yield10 Bioscience is strategically positioned to address critical challenges in modern agriculture.
How much funding has Yield10 Bioscience raised?
Yield10 Bioscience has raised a total of $119.5M across 4 funding rounds:
Stock Offering
$95.2M
Share Placement
$11.5M
Debt
$150K
Stock Offering
$12.7M
Stock Issuance/Offering (2006): $95.2M, investors not publicly disclosed
Share Placement (2019): $11.5M led by Jack W. Schuler
Debt (2020): $150K supported by PPP
Stock Issuance/Offering (2021): $12.7M, investors not publicly disclosed
Key Investors in Yield10 Bioscience
Jack W. Schuler
Jack W. Schuler is an individual investor who participated in a significant share placement, indicating a strategic interest in Yield10 Bioscience's agricultural technology.
PPP
Public-Private Partnership
What's next for Yield10 Bioscience?
The recent major strategic investment in Yield10 Bioscience suggests a phase of accelerated growth and development. This capital infusion is likely to be directed towards further research and development of its GRAIN platform and Camelina oilseed technology, potentially expanding its trait pipeline and commercialization efforts. The company's focus on improving crop yields and sustainability aligns with increasing global demand for food security, positioning Yield10 for significant market impact. Future endeavors may include strategic partnerships and broader market penetration as the company scales its innovative solutions.
See full Yield10 Bioscience company page
